Holen Sie sich die Stockscreener-App
15.45
10.91%
1.70
Handel nachbörslich:
15.30
-0.15
-0.97%
Schlusskurs vom Vortag:
$13.75
Offen:
$14.04
24-Stunden-Volumen:
188.85K
Relative Volume:
0.34
Marktkapitalisierung:
$44.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+13.30%
1M Leistung:
+66.12%
6M Leistung:
+260.52%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.75
$15.46
1-Wochen-Bereich:
$13.12
$15.65
52-Wochen-Spanne:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Vergleichen Sie QNTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
15.45 | 36.58M | 0 | 0 | 0 | 0.00 |
|
HLN
Haleon Plc Adr
|
11.07 | 50.98B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
170.02 | 74.41B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.99 | 4.03M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 46.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.78 | 20.10B | 16.54B | -1.64B | 749.00M | -1.45 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum BioPharma clarifies misinformation on stock name, RTO rumors By Investing.com - Investing.com South Africa
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO Rumors - citybuzz -
Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM S - GuruFocus
Quantum BioPharma clarifies misinformation on stock name, RTO rumors - Investing.com
Quantum BioPharma clarifies company has not changed its name - TipRanks
Quantum BioPharma (QNTM) Clarifies Company Name and Transaction Rumors | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation and Financial Agreements - TipRanks
Quantum BioPharma Addresses Misinformation Regarding Unbuzzd Wellness and Clarifies Stock Trading Platform Errors - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewswire
iNGENū CRO Partners with Quantum BioPharma to Launch - GlobeNewswire
Quantum BioPharma settles disputes with former CEO By Investing.com - Investing.com South Africa
Quantum BioPharma Resolves Legal Dispute with Former CEO, Secures $2.35 Million Settlement - citybuzz -
What's Going On With Quantum Biopharma Stock Today? - Benzinga
Quantum BioPharma (QNTM) Settles Disputes with Former CEO | QNTM Stock News - GuruFocus
Quantum BioPharma Settles Legal Dispute with Former CEO, Receives $2.35 Million - TipRanks
Quantum BioPharma settles disputes with former CEO - Investing.com
Quantum Biopharma Brief: Says Received US$2.35 Million From a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - marketscreener.com
Quantum BioPharma Receives $2.35 Million USD from a - GlobeNewswire
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - Yahoo Finance
Quantum BioPharma appoints MNP for IPO readiness audits By Investing.com - Investing.com South Africa
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment - citybuzz -
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | QNTM Stock News - GuruFocus
Quantum BioPharma’s Licensee Unbuzzd Wellness Prepares for IPO with Audit Firm Engagement - TipRanks
Quantum BioPharma announces Unbuzzd Wellness hired audit firm - TipRanks
Quantum BioPharma appoints MNP for IPO readiness audits - Investing.com Australia
Quantum BioPharma Ltd. Announces Unbuzzd Wellness Inc. Hires MNP LLP for PCAOB Audits Ahead of Possible IPO and Company Name Change - Nasdaq
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc. - GlobeNewswire
Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 - marketscreener.com
Quantum Group announces subsidiary received approval by HREC in Australia - TipRanks
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinica - GuruFocus
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinical Trial | QNTM Stock News - GuruFocus
Quantum BioPharma Gains Approval for Phase 2 Trial of FSD202 - TipRanks
Quantum BioPharma Receives Ethics Committee Approval for - GlobeNewswire
Breakthrough MCAS Pain Drug Advances: Quantum BioPharma's FSD202 Cleared for Phase 2 Trial - Stock Titan
Quantum BioPharma selects BitGo to securely store its cryptocurrency assets; - MSN
Quantum BioPharma selects BitGo for crypto custody By Investing.com - Investing.com South Africa
Quantum Biopharma Chooses BitGo to Store Cryptocurrency Holdings - marketscreener.com
Quantum BioPharma (QNTM) Partners with BitGo for Crypto Custody - GuruFocus
Quantum BioPharma Partners with BitGo for Crypto Asset Security - TipRanks
Quantum BioPharma selects BitGo for crypto custody - Investing.com
Quantum BioPharma Ltd. Partners with BitGo Trust for Secure Management of Cryptocurrency Assets - Nasdaq
Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets - GlobeNewswire
Cannabis Stocks To Follow Today – May 19th - Defense World
Quantum BioPharma advances MS drug towards Phase 2 trial By Investing.com - Investing.com South Africa
Quantum BioPharma advances MS drug towards Phase 2 trial - Investing.com Australia
Quantum Biopharma Announces Signing of an Agreement with a - GlobeNewswire
Endeavour Moves To Adjust Debt, Quantum Boosts Bitcoin Holdings - Finimize
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Es liegen keine Finanzdaten für Quantum Biopharma Ltd (QNTM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):